Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



GSK CEO addresses declining trust in vaccines following Trump re-election

November 07, 2024
GSK PLC CEO, Emma Walmsley, recently spoke out about the declining trust in vaccines following the re-election of President Trump. In her statement, Walmsley emphasized the importance of vaccines in preventing the spread of diseases and maintaining public health. She reassured the public that GSK is committed to producing safe and effective vaccines, and urged individuals to trust in the scientific community and the rigorous regulatory processes in place. As the world continues to battle the COVID-19 pandemic, GSK remains dedicated to developing a vaccine that will help bring an end to this global crisis.

Find out how the GSK PLC rate is expected to change

Get Forecast for GSK

Investor opinions & comments:

I appreciate GSK's commitment to producing safe and effective vaccines. Trust in the scientific community is crucial, especially during these uncertain times
— from GrowthGina at 11-10-2024 13:42
It's great to see GSK CEO addressing the declining trust in vaccines. I'm curious to learn more about the steps they are taking to ensure safety and effectiveness
— from EliWells at 11-09-2024 23:06
With the speed at which the COVID-19 vaccine is being developed, can we truly trust its safety and long-term effects?
— from ProfitPiper at 11-09-2024 21:00
I wonder if GSK will collaborate with other pharmaceutical companies to expedite the development of the COVID-19 vaccine
— from LucasPrice at 11-09-2024 16:15
I'm not so sure about the trust in vaccines. We've seen controversies arise in the past, and I hope GSK's claims of safety and effectiveness are backed up by solid evidence
— from CapitalCathy at 11-09-2024 06:37
I trust in the rigorous regulatory processes in place and I believe GSK will deliver a safe and effective vaccine. Let's support their efforts to end this global crisis
— from TraderTobias at 11-08-2024 00:36
If you want to leave a comment, then you need Login or Register





Other news for GSK

GSKJune 2, 2025QuantWave Delivers 7.39% Profit with Successful GSK PLC Stock Price Target Forecast  ~2 min.

On March 21, 2025, QuantWave, the automated forecasting platform, signaled a long position for GSK PLC at a price of 38.79 $. Today, on June 2, 2025, the stock reached the predicted target price of 41....

GSKJune 2, 2025QuantWave Hits Price Target Forecast for GSK PLC, Yielding 8.78% Profit  ~1 min.

QuantWave, the automated forecasting platform, successfully achieved its price target forecast for GSK PLC, resulting in a profit of 8.78%....

GSKJune 2, 2025QuantWave Achieves GSK PLC Price Target Forecast with 6.93% Profit  ~1 min.

QuantWave, the leading automated forecasting platform, has successfully hit the price target forecast for GSK PLC, resulting in a profitable trade with a 6.93% gain....

GSKJune 2, 2025QuantWave Achieves 8.39% Profit Target Forecast for GSK PLC Stock  ~1 min.

QuantWave, an automated forecasting platform, has successfully hit a price target forecast for the stock of GSK PLC, resulting in a profit of 8.39%....

GSKJune 2, 2025QuantWave Achieves 11.28% Profit Target Forecast for GSK PLC  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted a long position for GSK PLC on April 1, 2025, when the stock was trading at $37.44....



Related news

TSLAFebruary 4, 2025Trump Threatens Tesla Revenue Stream That's Never Been Bigger  ~2 min.

Tesla Inc. (TSLA) faces a potential threat to its revenue stream as President Donald Trump puts pressure on the sale of regulatory credits....

AZNJanuary 23, 2025Robbins LLP Encourages AZN Shareholders with Large Losses to Seek Counsel in the AstraZeneca PLC Class Action  ~2 min.

AstraZeneca PLC, a globally renowned pharmaceutical company, is facing a potential setback as Robbins LLP, a leading shareholder rights litigation firm, encourages AZN shareholders with significant losses to seek legal counsel in the AstraZeneca PLC class action. The class action alleges that AstraZeneca PLC made false and misleading statements regarding the efficacy and safety of its COVID-19 vac...

TRPFebruary 18, 2025TC Energy Announces Record EBITDA and Strategic Growth in Q4 2024  ~1 min.

TC Energy Corporation (NYSE:TRP) has filed its annual disclosure documents for 2024, showcasing the company's impressive financial performance and strategic growth....

RTXJanuary 25, 2025RTX Corporation Makes Statement on Presidential Executive Orders  ~1 min.

RTX Corporation, a leading technology company, has made a statement in response to recent Presidential Executive Orders....

Understanding and Implementing Hedging in Accounting for Risk Management  ~3 min.

In today's volatile financial market, managing risk is crucial for businesses of all sizes....